MoneyWorks4Me

Caplin Point Laboratories to consider dividend

12 Nov 2011 Evaluate

Caplin Point Laboratories has informed that a meeting of the board of directors of the company will be held on November 21, 2011, to consider the audited financial results of the company for the year ended June 30, 2011 and to consider the declaration of dividend, if any.

The above information is part of the company’s filing submitted to the BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..